Oral Session 2-15D Relapsed Aggressive Lymphoma: Treatment

[OS2-15D-2] Retrospective analysis of the salvage therapies and outcomes of relapsed DLBCL

Kyoko Yoshihara^1,7, Yoshifumi Shimizu^2,7, Hiroyuki Takatsuka^3,7, Hiroyuki Kawamoto^4,7, Satoshi Yoshihara^1,5,7, Tazuko Tokugawa^1,7, Akihiro Sawada^1,7, Hiroya Tamaki^1,7, Masaya Okada^1,7, Mahito Misawa^6,7, Hidetaka Ifuku^3,7, Yokiko Ooe^4,7, Yoshihiro Fujimori^1,5,7 (1.Hematology, Hyogo College of Medicine, Hyogo, Japan, 2.Takarazuka City Hospital, Hyogo, Japan, 3.Hematology, Amagasaki Chuo Hospital, Hyogo, Japan, 4.Hematology, Uegahara Hospital, Hyogo, Japan, 5.Transfusion Medicine/Cellular Therapy, Hyogo College of Medicine, Japan, 6.Hematology, Ako Central Hospital, Hyogo, Japan, 7.Mukogawa Hematology Study Group, Hyogo, Japan)